Skip to main content
Livermore
Livermore
ZHEN

First Turn Management, LLC

SEC CIK
0001993440
Latest filing
Aug 14, 2026

Holdings in Q4 2024

Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.

Institution overview
Positions
36
−2 vs. Q3 2024
Portfolio value
$558.3M
−$73.3M (−11.6%) vs. Q3 2024
Filed
Feb 14, 2025
SEC
Holdings of First Turn Management, LLC in Q4 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
INSMINSMED IncCOM PAR $.01446,980$30.9M5.5%+90,529+25.4%AddedHistory
VRNAVerona Pharma plcSPONSORED ADS641,901$29.8M5.3%+68,973+12.0%AddedHistory
XENEXenon Pharmaceuticals Inc.COM684,986$26.9M4.8%+359,768+110.6%AddedHistory
ARGXArgenx SESPONSORED ADR43,078$26.5M4.7%−11,362−20.9%ReducedHistory
ITCIIntra-Cellular Therapies, Inc.COM294,414$24.6M4.4%+39,614+15.5%AddedHistory
NUVLNuvalent, Inc.COM309,521$24.2M4.3%−49,593−13.8%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM453,376$23.2M4.2%+100,000+28.3%AddedHistory
PCVXVaxcyte, Inc.COM276,905$22.7M4.1%+64,920+30.6%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM506,908$21.0M3.8%−140,703−21.7%ReducedHistory
JANXJanux Therapeutics, Inc.COM383,602$20.5M3.7%+383,602NewHistory
VERAVera Therapeutics, Inc.CL A464,807$19.7M3.5%+138,313+42.4%AddedHistory
ISRGIntuitive Surgical IncCOM NEW35,032$18.3M3.3%+4,778+15.8%AddedHistory
RVMDRevolution Medicines, Inc.COM403,915$17.7M3.2%+403,915NewHistory
EXASExact Sciences CorpCOM309,890$17.4M3.1%+309,890NewHistory
AXSMAxsome Therapeutics, Inc.COM192,146$16.3M2.9%−63,148−24.7%ReducedHistory
NTRANatera, Inc.COM99,159$15.7M2.8%−56,491−36.3%ReducedHistory
GKOSGLAUKOS CorpCOM96,097$14.4M2.6%00.0%UnchangedHistory
GERNGeron CorpCOM3,893,327$13.8M2.5%+768,360+24.6%AddedHistory
BBIOBridgeBio Pharma, Inc.COM452,290$12.4M2.2%+52,509+13.1%AddedHistory
ASNDAscendis Pharma A/SSPONSORED ADR87,804$12.1M2.2%−62,789−41.7%ReducedHistory
HQYHealthequity, Inc.COM125,867$12.1M2.2%+125,867NewHistory
ELVNEnliven Therapeutics, Inc.COM535,092$12.0M2.2%00.0%UnchangedHistory
DAWNDay One Biopharmaceuticals, Inc.Stock947,878$12.0M2.2%00.0%UnchangedHistory
MRUSMerus N.V.COM285,159$12.0M2.1%−22,855−7.4%ReducedHistory
ADMAAdma Biologics, Inc.COM684,230$11.7M2.1%+19,245+2.9%AddedHistory
ORICOric Pharmaceuticals, Inc.COM1,451,037$11.7M2.1%00.0%UnchangedHistory
ACLXArcellx, Inc.COMMON STOCK152,356$11.7M2.1%−61,942−28.9%ReducedHistory
APGEApogee Therapeutics, Inc.COM252,725$11.4M2.1%+252,725NewHistory
HROWHarrow, Inc.COM304,874$10.2M1.8%−21,708−6.6%ReducedHistory
BHVNBiohaven Ltd.COM262,442$9.80M1.8%−53,374−16.9%ReducedHistory
CRMDCorMedix Inc.COM1,021,421$8.27M1.5%+1,021,421NewHistory
SPRYARS Pharmaceuticals, Inc.COM593,291$6.26M1.1%00.0%UnchangedHistory
BCAXBicara Therapeutics Inc.COM346,170$6.03M1.1%−216,221−38.4%ReducedHistory
BPMCBlueprint Medicines CorpCOM67,143$5.86M1.0%−111,786−62.5%ReducedHistory
SNDXSyndax Pharmaceuticals IncCOM441,587$5.84M1.0%−745,578−62.8%ReducedHistory
PRAXPraxis Precision Medicines, Inc.COM NEW45,536$3.50M0.6%+45,536NewHistory

Sold out since Q3 2024 (9)

Positions held at the end of Q3 2024 that are gone from this filing.

Positions of First Turn Management, LLC sold out since Q3 2024
SecurityClassShares in Q3 2024Value in Q3 2024% of portfolio in Q3 2024History
TMDXTransMedics Group, Inc.COM114,247$17.9M2.8%History
VRTXVertex Pharmaceuticals IncStock35,222$16.4M2.6%History
ESTAEstablishment Labs Holdings Inc.COM357,003$15.4M2.4%History
RGENRepligen CorpCOM88,714$13.2M2.1%History
KRYSKrystal Biotech, Inc.COM67,942$12.4M2.0%History
CYTKCytokinetics IncCOM NEW223,147$11.8M1.9%History
RCKTRocket Pharmaceuticals, Inc.COM621,306$11.5M1.8%History
RLAYRelay Therapeutics, Inc.COM1,226,354$8.68M1.4%History
KALVKalVista Pharmaceuticals, Inc.COM355,000$4.11M0.7%History